United Therapeutics (UTHR) Tops Q1 EPS by 41c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.97 +2.12%
Revenue Growth %: -1.2%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -1.2%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $2.55, $0.41 better than the analyst estimate of $2.14. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $353.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Chime to acquire Stride Bank for $590M in cash
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
